Stonegate Investment Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Stonegate Investment Group's ELV Position: Q3 2025 in Review
Stonegate Investment Group increased its Elevance Health (ELV) stake by 42% in Q3 2025, buying an estimated $69.4K and bringing the position to 748 shares worth $242K. The position accounts for 0.01% of the portfolio, ranked #359.
Stonegate Investment Group first reported a position in ELV in Q3 2024 and has held it in 4 quarters since. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.
- Stonegate Investment Group held 748 shares of Elevance Health worth $242K as of Q3 2025.
- Stonegate Investment Group bought 223 Elevance Health shares in Q3 2025, an estimated $69.4K.
- Elevance Health made up 0.01% of Stonegate Investment Group's portfolio in Q3 2025, its #359 holding.
- Stonegate Investment Group first reported a position in Elevance Health in Q3 2024 and has held it in 4 quarters since.
- 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.
Based on Stonegate Investment Group's 13F filing for Q3 2025, filed 3 Nov 2025.